Close Menu

Mass Genomics's Dan Koboldt rounds up a recent cancer genomics meeting in St. Louis, which included talks from Peter Campbell, Richard Gibbs, and Elaine Mardis, among others. Campbell introduced the Wellcome Trust Sanger Institute's first cancer genome; Gibbs spoke about Baylor's multiple-platform approach to whole genome sequencing; and Mardis gave an overview of the strategies being used at Washington University to use next-gen sequencing to study cancer genomes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.